文献速递呼吸危重症与机械通气

经上皮鼻电位差在急性呼吸窘迫综合征患者及高危人群中的预测价值

Transepithelial nasal potential difference in patients with, and at risk of acute respiratory distress syndrome.
PubMed 文献 · Thorax · 2021-04-22

这项前瞻性观察研究在15名健康对照和88名患者中测量鼻电位差(NPD),发现高危者中最大NPD(mNPD)升高可预测ARDS发生(AUC 0.75),ARDS患者mNPD高于高危者和对照,但mNPD对死亡预测能力有限(AUC 0.60)。

要点

  • 高危患者mNPD升高可预测ARDS发生,AUC 0.75。
  • ARDS患者mNPD高于高危者和健康对照。
  • mNPD对ARDS死亡预测能力有限,AUC 0.60。

核心结论

  • mNPD升高可预测高危患者发生ARDS,但不能预测死亡。
  • NPD在ARDS发生前升高,ARDS期间更高,但幸存者与对照无显著差异。

研究设计与样本

  • 前瞻性观察性研究,纳入15名健康对照和88名患者。
  • 患者包括40名机械通气高危者、61名ARDS机械通气患者(其中13名曾属高危组)和8名病房ARDS幸存者。

主要发现

  • 高危者中,发生ARDS者mNPD更高(差值-8.4 mV;95%CI -13.8至-3.7;p=0.005)。
  • mNPD预测高危者发生ARDS的AUC为0.75(95%CI 0.59至0.89)。
  • ARDS组中,幸存者与死亡者mNPD无显著差异(p=0.076),mNPD预测死亡的AUC为0.60(95%CI 0.45至0.75)。
  • ARDS患者mNPD(-30.8 mV)高于高危者(-24.2 mV)和对照(-19.9 mV)(p<0.001)。
  • 幸存者与对照的NPD无显著差异(p=0.18)。

临床怎么用

  • NPD可能作为反映内源性钠转运刺激机制的生物标志物。
  • 需更大规模研究确认NPD与ARDS的关联及预测性能。

局限性

  • 样本量有限,需更大研究验证。
  • mNPD对死亡预测能力有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Impaired alveolar fluid clearance, determined in part by alveolar sodium transport, is associated with acute respiratory distress syndrome (ARDS). Nasal sodium transport may reflect alveolar transport. The primary objective of this prospective, observational study was to determine if reduced nasal sodium transport, as measured by nasal potential difference (NPD), was predictive of the development of and outcome from ARDS. METHODS: NPD was measured in 15 healthy controls and in 88 patients: 40 mechanically ventilated patients defined as 'at-risk' for ARDS, 61 mechanically ventilated patients with ARDS (13 who were previously included in the 'at-risk' group) and 8 ARDS survivors on the ward. RESULTS: In at-risk subjects, maximum NPD (mNPD) was greater in those who developed ARDS (difference -8.4 mV; 95% CI -13.8 to -3.7; p=0.005) and increased mNPD predicted the development of ARDS before its onset (area under the curve (AUC) 0.75; 95% CI 0.59 to 0.89). In the ARDS group, mNPD was not significantly different for survivors and non-survivors (p=0.076), and mNPD was a modest predictor of death (AUC 0.60; 95% CI 0.45 to 0.75). mNPD was greater in subjects with ARDS (-30.8 mV) than in at-risk subjects (-24.2 mV) and controls (-19.9 mV) (p<0.001). NPD values were not significantly different for survivors and controls (p=0.18). CONCLUSIONS: Increased NPD predicts the development of ARDS in at-risk subjects but does not predict mortality. NPD increases before ARDS develops, is greater during ARDS, but is not significantly different for controls and survivors. These results may reflect the upregulated sodium transport necessary for alveolar fluid clearance in ARDS. NPD may be useful as a biomarker of endogenous mechanisms to stimulate sodium transport. Larger studies are now needed to confirm these associations and predictive performance.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Mac Sweeney R, Reddy K, Davies JC, et al. Transepithelial nasal potential difference in patients with, and at risk of acute respiratory distress syndrome. Thorax. 2021. PMID: 33888572. doi:10.1136/thoraxjnl-2020-215587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。